what do glp-1 agonists do GLP-1 Agonists In Obesity

Ryan et al

Syan SK, Smith M, Frey BN, Remtulla R, Kapczinski F, Hall GBC, et al

The results were consistent, and the safety profile looked similar to other GLP-1 drugs

Preclinical studies have demonstrated that the combination of liraglutide and medroxyprogesterone acetate produces a significantly stronger inhibitory effect on endometrial cancer cell proliferation compared to monotherapy, and this effect exhibits dose-dependency [58]

The overall heterogeneity for HHF was I 2 = 0% (95% uncertainty intervals, 0 and 48.0%) (null) (Additional file 1: Table S3), with no evidence of publication bias (Egger test, P = 0.413)

Important Drawbacks to Consider GLP-1s are not without downsides